WithdrawnNot Applicable

Effect of Remote Intervention in Patients With SCAD

Stopped: Unable to recruit enough patients

China0Started 2021-04-01

Plain-language summary

The study was a multicenter, two-arm, parallel, open-label, prospective clinical trial that evaluated a remote intervention with 1 year of follow-up.

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Aged between 18-99 years
✓. Diagnosed with SCAD according to guidelines by coronary CTA or coronary angiography (including stable angina, ischemic cardiomyopathy, and the stable course after acute coronary syndrome)
✓. Have sufficient Chinese language proficiency to reading, speaking and listening
✓. Live with at least one caregiver or guardian in the household
✓. Presence of stable hemodynamics without using vasopressor
✓. Able to individually consent
✓. Not participating in any other clinical trial

✕. Unable to provide informed consent
✕. Unable to be involved in clinical follow-up and treatment
✕. Suffered comorbidity with a life expectancy of less than 1 year
✕. Have contra-indication to cardiac rehabilitation
✕. Acute coronary syndrome
✕. History of noncompliance with medical therapy
✕. Severe valvular disease or valvular disease likely to require surgery or percutaneous valve replacement during the trial

Medication adherence

Timeframe: 1 year

NCT IDNCT04795492

SponsorChinese Academy of Medical Sciences, Fuwai Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-04